Founder.page ↗
Clicks.page ↗Manifold Bio
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
- Category
- SaaS
- Funding
- VC-backed
Every fact above is shown only where it could be checked against a source: funding against a primary source, backers against the investor’s own directory, and a location only where the company names that city on its own site. A row that is absent is one we could not source, not a zero. The summary is a written description of the company. Category is our own classification. Spotted something wrong? Tell us.
Frequently asked questions
What does Manifold Bio do?
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
Where is Manifold Bio based?
Location for Manifold Bio has not been disclosed publicly.
How much has Manifold Bio raised?
Manifold Bio is vc-backed. Funding details have not been disclosed.